
HTG Molecular Diagnostics HTGM
Annual report 2022
added 03-30-2023
HTG Molecular Diagnostics Operating Expenses 2011-2026 | HTGM
Annual Operating Expenses HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 24.1 M | 29.3 M | 32.6 M | 27.5 M | 25.3 M | 19.6 M | 13 M | 11.9 M | 11.2 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.6 M | 11.2 M | 21.6 M |
Quarterly Operating Expenses HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.27 M | 7.52 M | 8.25 M | - | 7.74 M | 6.03 M | 5.51 M | - | 5.85 M | 7.32 M | 6.69 M | - | 5.03 M | 4.68 M | 4.13 M | - | 3.26 M | 3.29 M | 2.93 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.27 M | 2.93 M | 5.77 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 19.72 | 2.71 % | $ 572 M | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 16.36 | 2.57 % | $ 495 M | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 114.94 | 1.22 % | $ 9.48 B | ||
|
Agilent Technologies
A
|
1.99 B | $ 113.33 | 2.5 % | $ 34.5 B | ||
|
Interpace Biosciences
IDXG
|
20 M | $ 1.8 | - | $ 7.96 M | ||
|
Celcuity
CELC
|
172 M | $ 138.86 | 6.03 % | $ 6.49 B | ||
|
Co-Diagnostics
CODX
|
50.6 M | $ 2.31 | 17.26 % | $ 3.07 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Illumina
ILMN
|
3.69 B | $ 141.35 | -0.24 % | $ 22.5 B | ||
|
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
226 M | $ 113.24 | 15.33 % | $ 14.2 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
411 M | $ 21.1 | 2.78 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 96.33 | 3.7 % | $ 6.5 B | ||
|
Medpace Holdings
MEDP
|
118 M | $ 421.05 | 0.27 % | $ 12.1 B | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 082.63 | 3.03 % | $ 22.3 B | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
38.5 M | $ 19.2 | 2.4 % | $ 430 M | ||
|
Natera
NTRA
|
258 M | $ 202.96 | 3.53 % | $ 20 B | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 156.38 | 2.59 % | $ 7.75 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Personalis
PSNL
|
44.5 M | $ 7.86 | 11.58 % | $ 701 M | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
430 M | $ 8.79 | 4.77 % | $ 1.13 B | ||
|
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
964 M | $ 3.74 | 5.21 % | $ 346 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 26.76 | 2.71 % | $ 25.4 B | ||
|
Thermo Fisher Scientific
TMO
|
7.15 B | $ 449.72 | 0.43 % | $ 170 B | ||
|
Senseonics Holdings
SENS
|
61.8 M | $ 5.69 | 2.62 % | $ 237 M | ||
|
Twist Bioscience Corporation
TWST
|
116 M | $ 54.25 | 9.6 % | $ 3.24 B | ||
|
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
181 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
5.64 M | $ 2.35 | -1.26 % | $ 5.4 M | ||
|
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.6 | 6.65 % | $ 216 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 257.11 | 1.35 % | $ 21.4 B | ||
|
Motus GI Holdings
MOTS
|
19.1 M | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
687 M | $ 341.81 | 2.57 % | $ 20.4 B | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 8.73 | 4.49 % | $ 1.89 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 193.73 | 1.75 % | $ 21.5 B |